Truist Financial Maintains Corcept Therapeutics(CORT.US) With Buy Rating

Futu NewsNov 4 20:35 · Ratings

Truist Financial Keeps Their Buy Rating on Corcept Therapeutics (CORT)

TipRanksNov 4 20:16 · Ratings

Earnings Call: Corcept Therapeutics Reports Robust Q3 Growth, Raises Guidance

InvestingNov 1 01:46

A Quick Look at Today's Ratings for Corcept Therapeutics(CORT.US), With a Forecast Between $67 to $80

Futu NewsOct 31 21:00 · Ratings

Corcept Therapeutics Analyst Ratings

BenzingaOct 31 19:16 · Ratings

Corcept Therapeutics Incorporated (CORT) Q3 2024 Earnings Call Transcript Summary

Futu NewsOct 31 09:12 · Conference Call